HOME > TOP STORIES

TOP STORIES

BUSINESS Lyrica Expected to Face Generic Onslaught by Year’s End as Patent Ruled Invalid

July 28, 2020
BUSINESS Nihon Chouzai Launches Drug Information Service with Standard Formulary Including Few New Meds

July 27, 2020
BUSINESS 9-Valent HPV Vaccine Hits Finish Line, but Japan Launch Schedule Uncertain with High Global Demand

July 22, 2020
BUSINESS AstraZeneca Aims to Deliver100 Million Doses of Coronavirus Vaccine to Japan: CEO

July 21, 2020
BUSINESS National CV Center Spin-Off Developing Oligonucleotide Therapy for Dyslipidemia, Eyes 1st Trial in FY2022

July 20, 2020
REGULATORY 2020 Policy Blueprint Restresses Efforts on COVID-19 Meds/Vaccines; Drug Price Survey Up for Discussion on July 22

July 20, 2020
REGULATORY Japan Govt Adopts 2020 Honebuto Policy, Drug Price Survey to Be Conducted This Autumn

July 17, 2020
BUSINESS Kyowa Pharma Expanding Focus Beyond Drugs, Eyes New Diagnostic/Treatment Options in CNS

July 17, 2020
REGULATORY Japan Govt to Push Ahead with Off-Year Survey, Considering COVID-19 Impact to Decide on Re-Pricing

July 16, 2020
REGULATORY Japan Govt to Tweak Honebuto Text for Off-Year Re-Pricing, but Still Holds to Original Plan

July 15, 2020
BUSINESS Shionogi, Ping An to Set Up JV in August, Make It a Hub for China/Asia Biz

July 14, 2020
BUSINESS Takeda Looks to Derive 70%-Plus of Japan Sales from 5 Focus Areas by FY2025, Revamp HR Systems

July 13, 2020
ACADEMIA Avigan Fails to Hit Statistical Significance in COVID-19 Trial: Fujita Health Univ.

July 13, 2020
COMMENTARY Diabetes Market Regaining Momentum with New Launches; First Oral GLP-1 a Game Changer?

July 13, 2020
BUSINESS Bayer Revving Up Cell Therapy Drive with First Focus on Parkinson’s, Japan Biz Also Eyed: R&D Chief

July 10, 2020
REGULATORY LDP Lawmakers Irked as Govt Stands Fast on Off-Year Re-Pricing/Survey Plan; Honebuto Text Tweak Unclear

July 10, 2020
REGULATORY Original Plan Remains Unchanged for Off-Year Drug Re-Pricing, Survey: Minister

July 9, 2020
BUSINESS Aducanumab Filing Completed in US; Talks with Japan/EU Regulators Ongoing

July 9, 2020
ORGANIZATION Mobile Pharmacy Van Set in Motion as Kumamoto Downpour Hits Local Stores, Some Wholesalers

July 8, 2020
ORGANIZATION Wholesaler Group Makes Emergency Plea against Off-Year Drug Price Survey

July 7, 2020

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

G1 Rule to Hit Originator Biologics for First Time, Impact Seen for Up to 13 Brands

By Shinya Sato

Japan’s FY2026 drug pricing reform will, for the first time, apply the “G1” price cut rule for long-listed original biologics…

COLUMN

The Strategic MSL: Beyond Data Delivery, It’s About Impact

By Philip Carrigan

I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…